Tectonic Therapeutic, Inc. cotiza a 22.35 USD y tiene una capitalización bursátil de $437M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The com…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.18 | $-1.34 | $-1.03 |
| Estimado | $-1.21 | $-1.35 | $-1.17 | $-1.11 |
| Sorpresa | — | +12.6% | -14.5% | +7.2% |
| Métrica | TECX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -29.5% | -40.4% | +10.9% |
| ROA | -28.4% | -32.0% | +3.6% |
| Current Ratio | 26.63 | 2.84 | +23.79 |
| Debt / Equity | — | 0.28 | — |